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Abstract
Tissue-specific transcriptional regulation is central to human disease1. To identify regulatory 
DNA active in human pancreatic islets, we profiled chromatin by FAIRE (Formaldehyde-Assisted 
Isolation of Regulatory Elements)2–4 coupled with high-throughput sequencing. We identified 
~80,000 open chromatin sites. Comparison of islet FAIRE-seq to five non-islet cell lines revealed 
~3,300 physically linked clusters of islet-selective open chromatin sites, which typically 
encompassed single genes exhibiting islet-specific expression. We mapped sequence variants to 
open chromatin sites and found that rs7903146, a TCF7L2 intronic variant strongly associated 
with type 2 diabetes (T2D)5, is located in islet-selective open chromatin. We show that rs7903146 
heterozygotes exhibit allelic imbalance in islet FAIRE signal, and that the variant alters enhancer 
activity, indicating that genetic variation at this locus acts in cis with local chromatin and 
regulatory changes. These findings illuminate the tissue-specific organization of cis-regulatory 
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elements, and show that FAIRE-seq can guide identification of regulatory variants important for 
disease.
Pancreatic islets are composed of endocrine cells that secrete insulin, glucagon, and other 
polypeptide hormones. Islet cells are essential for glucose homeostasis, and thus elucidating 
the transcriptional control of islet-cell function and growth has implications for 
understanding diabetes pathogenesis and treatment6,7. Gene regulatory elements often 
function by recruiting DNA-associated proteins to specific loci, a process that typically 
results in local nucleosome eviction8. Nucleosome loss, or formation of “open chromatin”, 
is an evolutionarily conserved indicator of regulatory activity and can be used as a molecular 
tag to isolate regions of the genome bound by regulatory factors9.
For three samples of purified human pancreatic islets, we used FAIRE2–4 to identify sites of 
open chromatin (Fig. 1a, Table 1, Supplementary Table 1 online). We technically validated 
FAIRE-seq by its high concordance to patterns determined by hybridization of the same 
FAIRE samples to tiling DNA microarrays (Fig. 1b, Supplementary Fig. 1a online). 
Furthermore, we found that despite differences in age, cause of death, genotype, islet 
isolation procedures, and level of exocrine cell contaminants, the majority of regions 
identified by FAIRE in any one sample were also detected in the others (Supplementary Fig. 
1b online). Thus, FAIRE-seq is a robust method for characterizing chromatin in islets.
Several lines of evidence indicate that FAIRE reliably identifies active regulatory elements 
in islets. Consistent with FAIRE in fibroblasts2, the most enriched FAIRE regions were 
found near known Transcription Start Sites (TSS) (Fig. 2a). Overall, there was a positive 
relationship between FAIRE signal near TSS and transcript levels in human islets10 (Fig. 
2a). Furthermore, promoters previously shown to bind RNA Polymerase II and the 
transcription factors HNF4A and HNF1A in islets11 were enriched by FAIRE more 
frequently than other promoter regions (Fig. 2b).
To extend this observation, we identified regulatory regions that were utilized selectively in 
islets relative to other cell types. We compared FAIRE-seq data from islets to data from five 
non-islet cell lines (HeLa-S3, HUVEC, GM12878, HepG2 and K562; Methods) and found 
that 45% of islet open chromatin sites were unique to islets among this group of cell types. 
We refer to these sites as islet-selective open chromatin. We identified 340 RefSeq genes 
with islet-selective open chromatin in the TSS or gene body (Supplementary Table 2 
online). This relatively short list included 24 well characterized genes that are selectively 
expressed in islets (Supplementary Table 3 online), including genes involved in human 
diabetes (PDX1, ABCC8, SLC30A8, G6PC2, GAD2) and islet developmental regulators 
(NEUROD1, NKX6-1, PAX6, ISL1)6,7,12–14. Therefore, islet-selective open chromatin 
detected by FAIRE identifies loci integral to islet-cell biology and disease.
Many sites of open chromatin detected by FAIRE are located in intergenic regions, far (>2 
kb) from a known TSS. For these distal sites, evidence also points strongly toward a 
regulatory function. First, distal intergenic open chromatin sites were enriched in 
evolutionary conserved sequences, predicted transcription factor binding sites and regulatory 
modules, regardless of whether the open chromatin was islet-selective or ubiquitous (shared 
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by all six cell types) (Fig. 2c, Supplementary Fig. 1d and Supplementary Table 4 online, 
Methods). Second, ubiquitous intergenic open chromatin often coincided with binding sites 
of CTCF15–17 (observed 16%, expected 0.39%, P<0.001) (Fig. 2c), a transcriptional 
regulator and insulator protein that binds to a large number of genomic sites, many of which 
are shared in different cell types16. Open chromatin at CTCF sites was centered at the 
location of the CTCF binding15, suggesting that FAIRE signal is indicative of interactions 
between regulatory factors and DNA (Fig. 2d). Third, intergenic islet-selective (but not 
ubiquitous) open chromatin preferentially harbors DNA-binding motifs of pancreatic islet 
transcription factors, including RFX, TCF1/HNF1, HNF3B, FOXD, and MAF (P<0.01, 
Supplementary Table 4 online). Notably, whereas ~36% of ubiquitous open chromatin was 
located within 2 kb upstream of a TSS or in the first exon, only 1% of islet-selective open 
chromatin was located in these regions (Fig. 2e, Supplementary Fig. 1c online). Collectively, 
these findings indicate that distal FAIRE sites harbor regulatory elements, and consistent 
with recent studies of histone modification patterns in enhancer regions18 suggest that most 
cell-type specific open chromatin is located far from known TSS.
We next sought to link these distal islet-selective elements to specific genes. We examined 
whether islet-selective sites exhibit a higher-order organization that could point to the 
existence of functional domains. We found that open chromatin sites were not evenly 
distributed throughout the genome, but instead were located in physically linked clusters 
(Fig. 3a). Clustering was also observed with islet-selective open chromatin (Fig. 3b). We 
identified 3,348 domains containing at least three islet-selective open chromatin sites 
separated by less than 20 kb, which we call islet-selective COREs (Clusters of Open 
Regulatory Elements) (Fig. 3c, Supplementary Table 5 online, Methods). Islet-selective 
COREs had a median size of 25 kb, with the largest containing 148 FAIRE sites spanning 
602 kb (Fig. 3d). Consistent with CTCF binding to insulator elements separating chromatin 
domains19, the frequency of CTCF binding sites was two-fold higher outside than within 
COREs (P=1.3×10−48). This suggested that islet-selective COREs were functional 
chromatin domains and provided an avenue to assigning open chromatin sites to genes.
Islet-selective COREs were located within 10 kb of at least one RefSeq gene in 69% of 
cases (randomized COREs=54%; P=1.5×10−35, Fig. 3e). Of these, 94% were associated 
with only one gene, and most were contained within 2 kb of gene boundaries 
(Supplementary Fig. 2 online) suggesting single-gene regulatory function (expected=84%; 
P=6.2×10−23, Fig. 3e, Methods). Compared to six other primary tissues, genes overlapping 
islet COREs had higher expression in islets and brain (one-way ANOVA, both tissues 
P<1×10−5, Fig. 3f), consistent with the neuroendocrine nature of islet-cells20. Islet-selective 
COREs were also enriched in genes linked to islet-specific functions, including transcription 
factors, ion channels, and secretory apparatus components (Table 2, Supplementary Table 6 
online). Thus, islet-selective COREs are typically linked to single genes that are expressed 
in an islet-selective manner.
A subset of islet-selective COREs spanned remarkably broad distances at loci encoding 
critical regulators of pancreas development and function (Fig. 3g, Supplementary Table 7 
and Supplementary Figs. 2 and 3 online). For example, an islet-selective CORE spanned a 
46-kb domain containing PDX1, a master regulator of pancreas development and β-cell 
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function7 (Fig. 3g). At this locus, FAIRE sites coincided with previously characterized 
evolutionarily conserved enhancers named “Area I–IV”21,22 and with uncharacterized 
putative enhancer sites (Fig. 3h). Other islet-selective COREs included a 94-kb domain 3′ of 
NKX6-1, an essential regulator of β-cell differentiation23, one located in a cluster of brain-
enriched snoRNA and miRNAs24, and another in conserved sequences >400 kb from any 
annotated gene (Supplementary Fig. 3 and Supplementary Table 7 online for additional 
examples). Such domains contrasted with loci devoid of open chromatin and known to be 
inactive in islets (Supplementary Fig. 3q–s). This dataset thus provides a rich resource to 
dissect cis regulation in pancreatic islets.
Recent genome-wide association studies for T2D susceptibility have implicated sequence 
variants at multiple loci, many of which may impair islet-cell function13,14,25–27. Many 
T2D susceptibility loci do not contain strongly associated variants in protein-coding regions, 
suggesting that the underlying functional variants regulate gene activity. Furthermore, at 
each locus, most associated SNPs are not expected to directly affect disease risk and are 
instead in linkage disequilibrium with one or more functional variant(s). We sought to use 
our open chromatin map to guide identification of functional regulatory SNPs. We identified 
known SNPs mapping to islet FAIRE sites and focused on 20 loci harboring variants 
associated with T2D or fasting glycemia (FG)5,13,14,25,28 (Fig. 4a, and Supplementary 
Table 8 online). Of 350 SNPs in strong linkage disequilibrium with a reported SNP 
associated with T2D or FG (Methods), 38 SNPs at 10 loci overlapped islet FAIRE regions 
(Fig. 4a, and Supplementary Table 8 online). Notably, rs7903146 in TCF7L2, which shows 
consistent T2D association in samples across diverse ethnic groups29, is located in an islet-
selective open chromatin site (Fig. 4b, and Supplementary Fig. 4a online).
The presence of rs7903146 in a FAIRE-enriched site allowed us to test directly whether 
sequence variation at this locus correlates with chromatin state in islet cells. We tested 31 
human islet samples and identified nine individuals heterozygous at rs7903146. Using two 
independent assays, FAIRE-isolated DNA from heterozygous individuals exhibited a T:C 
allelic ratio that was significantly greater than observed from input genomic DNA or from 
genomic DNA from unrelated heterozygote individuals (Real-time PCR: input: 49.3±1.0% T 
allele, FAIRE: 57.3±2.8% T allele, P=2.1×10−5, Fig. 4c; Quantitative sequencing: input: 
57.5 ± 2.7% T allele, FAIRE: 66.2 ± 4.6% T allele, P=0.004, Fig. 4d and Supplementary 
Fig. 4b online). Thus, in human islet cells, the chromatin state at rs7903146 is more open in 
chromosomes carrying the T allele, which is associated with increased T2D risk5.
Next, we created allele-specific luciferase reporter constructs and measured enhancer 
activity in two islet β-cell lines, MIN6 and 832/13. Allelic differences in enhancer activity 
were observed in both cell lines. The T allele showed significantly greater enhancer activity 
compared to the C allele in both orientations (Forward: MIN6 P=1.6×10−7, 832/13 P=0.005; 
Reverse: MIN6 P=3.1×10−7, 832/13 P=3.1×10−4, Fig. 4e,f, Supplementary Fig. 4c,d online). 
However, allele-specific differences were not observed in the human embryonic kidney cell 
line 293T (Supplementary Fig 4e online). These data suggest that sequence variation at 
TCF7L2 affects T2D susceptibility by altering cis regulation and local chromatin structure in 
islet cells. The results are consistent with a previous report of association between the T 
allele and increased TCF7L2 transcripts in islets29, although the allele-specific changes 
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described here can potentially impact different genomic regulatory functions, including 
transcriptional rates, promoter usage, or splicing.
To our knowledge, this study represents the first high-resolution atlas of regulatory elements 
in pancreatic islets. The unbiased maps generated by FAIRE-seq reveal new insights 
regarding the organization of tissue-specific cis-regulatory elements. Many earlier studies 
have shown that the genome is functionally organized in chromosomal territories1,30–32. 
Our observations extend previous findings by uncovering the existence of a large number of 
cell-selective regulatory domains associated with single genes, and provide a foundation for 
mechanistic understanding of transcriptional regulation of genes important for pancreatic 
islet cells. Identification of regulatory sites in a disease-relevant primary tissue also serves to 
dramatically reduce the genomic space when searching for functional non-coding sequence 
variants that influence T2D susceptibility. More generally, the current study provides a 
framework to move forward from the identification of large sets of disease-associated 
variants toward understanding the subset of functional variants that underlie disease risk.
Data accession numbers
Human islet FAIRE-seq raw data, alignments in the form of mean-centered base counts, and 
enriched sites at the three thresholds for all three samples can be obtained from Gene 
Expression Omnibus (GSE17616).
Methods
Islet sample preparation
All experiments were performed according to protocols approved by the Institutional ethical 
committees of the Hospital Clinic de Barcelona, Geneva University Hospitals, Istituto 
Scientifico Ospedale San Raffaele, and Hospital Universitari de Bellvitge. All samples were 
isolated from multiorgan donors without a history of glucose intolerance after informed 
consent from family members. Information on samples used for FAIRE-Seq are provided in 
Supplementary Table 1 online. Pancreatic islets were isolated according to established 
procedures33. After isolation, islets were cultured in CMRL 1066 containing 10% FCS and 
shipped at room temperature in the same medium. Samples 1 and 2 were processed upon 
arrival, while sample 3 and subsequent samples used in locus-specific assays were 
recultured in RPMI 1640 containing 10% FCS for three days before performing FAIRE. 
Islets were rinsed with PBS three times, and crosslinked for 10 min in 1% formaldehyde at 
room temperature with constant shaking. After adding glycine (final concentration 125 
mM), islets were rinsed with PBS containing protease inhibitor cocktail (Roche) at 4°C, 
snap frozen, and stored at −80°C. Islet purity was assessed by dithizone staining34 
immediately prior to fixation. The accuracy of dithizone staining was verified by 
immunofluorescence analysis using DAPI, anti-insulin, and anti-glucagon antibodies35.
FAIRE
For all but 2 samples (see below), FAIRE was performed as described2 with modifications. 
Frozen pellets with ~3000 crosslinked islets were thawed on ice in 1 mL lysis buffer (2% 
Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-Cl at pH 8.0, 1 mM EDTA) and 
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disrupted with five 1-minute cycles using 0.5 mm glass beads (BioSpec). Samples were 
sonicated for 10–20 rounds of 30 pulses (1 second on/0.5 second off) using a Branson 
Sonifier 450D at 15% amplitude. After 10 rounds the efficiency of sonication was assessed, 
and further rounds were performed when needed to ensure that the majority of chromatin 
fragments were in the 200–1000 bp range. Debris was cleared by centrifugation at 15,000 g 
for 5 minutes at 4°C. Nucleosome-depleted DNA was extracted with phenol-chloroform 
followed by ethanol precipitation and RNase A (100 µg/mL) treatment2.
For samples 1 and 2 we employed a modified procedure that yielded less consistent 
chromatin fragmentation. Cells were incubated with 50 mM HEPES (pH 8.0), 140 mM 
NaCl, 1 mM EDTA, 0.1% SDS, 0.1% sodium deoxycholate, then centrifuged at 9,000 g 10 
min. The pellet was resuspended in 50 mM HEPES (pH 8.0), 140 mM NaCl, 1 mM EDTA, 
1% Triton X-100, 0.1% SDS, 0.1% sodium deoxycholate, and then processed as described 
above.
Sequence analysis
Libraries were generated from gel-purified ~200 bp DNA fragments. After adaptor ligation 
and PCR-based amplification, samples were sequenced on the Illumina Genome Analyzer II 
platform using standard procedures. Sequence reads were aligned to the human reference 
genome (hg18) using Mapping and Assembly with Qualities (MAQ) with default mapping 
parameters 36. Post-alignment processing removed all reads that had an overall MAQ 
mapping quality <30 and artificially extended each read to a final length of 200 bp. We 
counted filtered reads mapping to each base in the genome to obtain a read density for each 
base. To facilitate display, read densities were centered on the mean read density of each 
chromosome.
Sites of FAIRE-seq enrichment were assessed with F-Seq37, which uses a kernel density 
estimate to calculate genomic regions where the continuous probability is greater than a 
user-defined standard deviation threshold over the mean across a local background. We used 
a feature length of 1,000 and three standard deviation (s.d.) thresholds resulting in three sets 
of enriched regions for each sample. The most liberal threshold was set for each sample 
using an empirical estimation of the upper bounds on the number of nucleosome-depleted 
regions genome-wide (roughly 200,000). For sample 3, the thresholds used were s.d.=6 
(liberal), s.d.=8 (moderate) and s.d.=10 (stringent). For samples 1 and 2, which were 
sequenced to a lower depth, the thresholds used were s.d.=4 (liberal), s.d.=5 (moderate) and 
s.d.=8 (stringent).
We estimated the mappable proportion of the reference genome in two ways, using 120 
million randomly generated reads (2.7×109 mappable bases, ~85% of hg18) and using 
PeakSeq (2.8×109 mappable bases, ~89% of hg18)38. We independently calculated genome 
coverage using 125 million reads obtained from islet FAIRE and found it to be 97.9% and 
97.7% concordant, respectively.
Sequence reads obtained from five major ENCODE cell lines (GM12878, HeLa-S3, 
HUVEC, K562, and HepG2) were aligned to the reference genome (hg18) using MAQ36 
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and filtered as described above. Sites of enrichment were determined using F-Seq37, using 
the same parameters as islet samples 1 and 2.
Microarray analysis
Islet FAIRE preparations from samples 1 and 2 were fluorescently labeled and hybridized to 
a tiling DNA microarray covering 1% of the genome selected for the ENCODE pilot 
project1. Sites of enrichment were called using ChIPOTle39. For Receiver Operating 
Characteristic (ROC) curve analysis, sites of enrichment were called using a p-value 
threshold of 1×10−12.
Regulatory feature analysis
We recorded the percentage of bases underlying FAIRE-seq sites that overlapped 28-species 
conserved elements40, predicted regulatory modules (PreMod)41 and transcription factor 
binding sites (TRANSFAC42 and MotifMap43). For each set of peaks we permuted 
positions across the mappable genome 1,000 times and re-calculated the overlap. P values 
were calculated from permutations that had a higher degree of overlap than the observed set 
of peaks. We used Clover to test for over-represented transcription factor binding motifs in 
sequences underlying intergenic FAIRE-seq enrichment44. Sequences were separated by 
chromosome and analyzed for motifs from JASPAR45 and TRANSFAC42, as well as the 
CTCF motif15. Significance was calculated by comparing to the mappable intergenic 
portion of the tested chromosome, and motifs reaching a p-value threshold of .01 were 
reported.
FAIRE-Seq and expression level analysis
We used RMA-normalized signals from a previously reported experiment using HG-U133A 
and HG-U133B GeneChips with five non-diabetic islet samples10, and obtained an average 
value for each probe. The five samples were selected by hierarchically clustering expression 
data from 7 non-diabetic individuals. We excluded two samples (Sydp2 and SydPI) that had 
poor concordance with the others and showed low expression of known islet genes. We 
counted the number of FAIRE-Seq reads mapping to each base in a 1 kb window 
surrounding each RefSeq TSS, grouped RefSeq genes by their average islet expression level, 
and, for each group, calculated the average mean-centered FAIRE read density at every base 
in the window.
Islet-selective and ubiquitous site definitions
An islet FAIRE-seq site was considered islet-selective if the site did not overlap a site from 
any of the five additional tested cell types. Note that such sites are not expected to be 
necessarily unique to islets. An islet site was considered ubiquitous if the site overlapped a 
FAIRE-seq site in all five additional cell types. Moderate stringency FAIRE-seq site 
thresholds were used for all datasets.
Selection of genes with islet-selective open chromatin
For each RefSeq transcript we assessed the region 2 kb upstream through 2 kb downstream 
and calculated the percentage of bases that overlapped a moderate islet FAIRE enrichment 
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site. We calculated the same value in the combined data from five non-islet cell lines, and 
selected genes that were more or equally enriched in islets compared to combined non-islet 
data.
Clusters of Open Regulatory Elements (COREs)
We identified 3,348 regions with at least three islet-selective sites (as defined above) located 
<20 kb from each other using Galaxy46. These criteria were based on the typical size of 
islet-selective clusters (Fig. 3b). For comparisons we created a set of randomized COREs of 
identical size and mappability. To assess CTCF binding enrichment, we obtained CTCF 
binding sites from multiple cell types17, calculated the frequency within COREs (0.007 
sites/kb), in randomized COREs (0.013 sites/kb), and in the mappable genome (0.013 sites/
kb), and tested for significance using a two-sided χ2 test.
RefSeq, ncRNA, or Non-RefSeq Unigene transcripts were assigned to a CORE when the 
transcriptional start or end site was within 10 kb of either end of the CORE. When 
comparing CORE overlaps with one or more genes we required a minimum overlap of one 
bp. We used DAVID47 to test enrichment of biological processes in CORE genes, and used 
all RefSeq genes as a background. We employed all biological processes from GO and 
PANTHER48, removing GO terms associated with >1,000 genes from the analysis.
For gene expression comparisons, we obtained gcRMA-normalized signals from Human 
U133A and GNF1H microarrays from seven tissues (pancreatic islet, liver, heart, kidney, 
lung, skeletal muscle and whole brain)49. We required that probes reported a signal of >100 
in at least one tissue. We used one-way ANOVA to assess expression differences between 
tissues for CORE genes and for an identical number of randomly selected genes that did not 
overlap a CORE.
Definition of T2D susceptibility variants
We identified 20 loci where SNPs have been reported to show genome-wide association 
(P<5×10−8) with T2D or fasting glycemia14,25,26,50–54. For each locus we identified 
variants in HapMap CEU release 22 in strong linkage disequilibrium (r2>0.8) with the 
reported reference SNP; 350 variants satisfied these criteria and were termed ‘T2D-
associated SNPs’. We then defined the region of association for each locus by manually 
identifying recombination hotspots from HapMap release 22 data flanking the associated 
SNPs. We identified SNPs in dbSNP v129 with an average heterozygosity >1% in these 
regions. SNPs that overlapped FAIRE sites in sample 3 were recorded.
Detection of allelic imbalance in open chromatin and PCR analysis of FAIRE
We genotyped 31 human islet genomic DNA (gDNA) samples using TaqMan SNP 
Genotyping Assays (Applied Biosystems). Nine samples were heterozygous for rs7903146. 
For these samples we used TaqMan SNP Genotyping Assays to determine the allelic ratio of 
DNA fragments containing rs7903146 in FAIRE and input DNA. All reactions were 
performed in triplicate in a volume of 25 µl using 5 ng DNA quantified with a Nanodrop 
1000 (Thermo Scientific). A standard curve was generated by mixing gDNA from samples 
with known genotype to generate seven allelic ratios - 10:90, 20:80, 40:60, 50:50, 60:40, 
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80:20, and 90:10. The relative abundance of T and C alleles in each experimental sample 
was estimated from the standard curve, and compared to input DNA from the same samples 
and gDNA from unrelated heterozygous individuals. Allelic ratio was also assessed in seven 
samples heterozygous for rs7903146 by quantitative Sanger sequencing in FAIRE and input 
DNA (oligonucleotides shown in Supplementary Table 9 online). ImageJ was used to 
quantify the area under the curve of peaks in the chromatogram. Data are expressed as mean 
± s.d. and were assessed with two-sided unpaired t-tests for gDNA vs. FAIRE, or paired t-
tests for input vs. FAIRE.
To confirm islet-selective FAIRE enrichments, we employed real-time PCR with SYBR 
Green detection as described55,56. We performed triplicate measurements from 5 ng FAIRE 
DNA, and used a serial dilution of input DNA as the standard curve. We expressed FAIRE 
enrichment values relative to the enrichment values in the same sample at a local negative 
control region.
Luciferase reporter assays
A 240 bp fragment surrounding rs7903146 was PCR-amplified from DNA of individuals 
homozygous for either the T or C allele of rs7903146 (oligonucleotides shown in 
Supplementary Table S9 online). PCR fragments were cloned in both orientations in the 
multiple cloning site of the minimal promoter-containing firefly luciferase reporter vector 
pGL4.23 (Promega). Four independent clones for each allele for each orientation were 
verified by sequencing and transfected in duplicate into MIN657 and 832/13 (Chris 
Newgard, Duke University) β-cell lines, and into HEK293T cells. Cells were co-transfected 
with a phRL-TK Renilla-luciferase vector to control for transfection efficiency. 
Transfections were performed with lipofectamine 2000 (for MIN6 and HEK 293T; 
Invitrogen) or FUGENE-6 (for 832/13; Roche Diagnostics). Cells were assayed 48 hours 
after transfection using the Dual Luciferase Assay (Promega). Firefly luciferase activity was 
normalized to Renilla luciferase activity and then divided by values for a pGL4.23 minimal 
promoter empty vector control. A two-sided t-test was used to compare luciferase activity 
between alleles. Experiments in MIN6 and 832/13 cells were carried out on a second 
independent day and yielded comparable allele-specific results.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. FAIRE-seq in human pancreatic islets
(a) Chromatin is cross-linked using formaldehyde, sonicated, and subjected to phenol-
chloroform extraction. DNA fragments recovered in the aqueous phase are then sequenced. 
(b) Reads obtained from sequencing were highly concordant with FAIRE signal obtained 
from tiling microarrays covering the ENCODE pilot project regions. Arrows indicate the 
direction of gene transcription.
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Figure 2. Both proximal and distant FAIRE sites harbor functional regulatory elements
(a) Genes with high expression in islets (top 20%; red) have more FAIRE enrichment at 
promoters than genes with moderate (middle 20%; green) or low (bottom 20%; blue) 
expression. (b) Promoters (−750/+250 bp) bound by RNA Pol II, HNF4A or HNF1A in 
human islets11 are significantly over-represented among islet FAIRE sites (red dash 
indicates expected value; all bars: P<0.001). (c) Intergenic islet-selective and ubiquitous 
FAIRE sites that are located >2 kb from a TSS are enriched for evolutionary conserved 
sequences (P<0.001), predicted regulatory modules (PreMod, P<0.001), and transcription 
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factor binding sites (conserved TFBS and MotifMap, both P<0.001). CTCF binding, 
however, is enriched in ubiquitous FAIRE sites only. Over half of intergenic open chromatin 
sites are coincident with an experimentally or computationally determined functional 
annotation (expected value for random sites: 27%). (d) Open chromatin is most enriched 
directly at sites of experimentally determined CTCF binding. (e) In contrast to ubiquitous 
FAIRE sites, islet-selective FAIRE sites are rarely located within 2 kb upstream of a TSS or 
in exon 1, and are instead located predominantly in more distal regions. Shown is the 
percentage of bases covered by each annotation category in islet-selective FAIRE sites 
(blue), ubiquitous FAIRE sites (red), and the mappable genome (gray).
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Figure 3. Islet-selective FAIRE sites form Clusters of Open Regulatory Elements (COREs)
(a) FAIRE sites are highly clustered. We divided the genome in windows of varying size (x 
axis), and calculated a χ2 statistic to determine if the number of windows with 0, 1 or >1 
FAIRE sites differed from randomly distributed sites. The highest significance was observed 
in ~20 kb windows. (b) Same as (a) but for islet-selective sites. (c) We defined islet-
selective clusters of open chromatin regulatory elements (COREs) as three or more islet-
selective FAIRE sites separated from each other by <20 kb. (d) We identified 3,348 islet-
selective COREs (blue points). Fewer COREs were generated using randomized FAIRE 
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sites (orange points), and they were smaller than in vivo COREs (e) Most islet-selective 
COREs were associated with a single gene. (f) RefSeq genes associated with islet-selective 
COREs were on average inactive in non-islet human tissues, except for brain. Asterisks 
indicate P<1×10−5 (one-way ANOVA). (g) Chromatin landscape of the PDX1 locus 
showing an extended cluster of islet-selective FAIRE sites, contrasting with a closed 
conformation of the adjacent gut-specific homeodomain gene CDX2. The top panel depicts 
the density of FAIRE-Seq reads centered on the genomic average density value, the location 
of moderate stringency FAIRE sites in islets (blue) or in any of the 5 non-islet cells (red), 
and the binding sites of the CTCF insulator protein in K562 cells. CTCF sites demarcate 
regions that show broadly consistent FAIRE-Seq enrichment patterns. The bottom panel 
shows a closer view of a portion of the PDX1 islet-selective CORE, with islet-selective open 
chromatin sites at previously characterized regulatory elements (Area I–III, Area IV) and in 
an evolutionarily conserved putative enhancer.
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Figure 4. Allele-specific open chromatin and enhancer activity at the TCF7L2 locus
(a) Schematic representation of how FAIRE-seq enables the identification of human 
sequence variants located in islet open chromatin. From ~4 million SNPs present in dbSNP 
with average heterozygosity >1%, 38 SNPs associated with T2D or fasting glycemia 
mapped to islet open chromatin sites. The analysis was carried out with all SNPs in strong 
linkage disequilibrium (r2>0.8) with an FG- or T2D-associated variant, which are labeled as 
FG or T2D SNPs, and FAIRE-seq sites identified with a liberal threshold. (b) Among 
TCF7L2 variants in linkage disequilibrium with rs7903146 (r2>0.2, top panel), only 
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rs7903146 maps to an islet-selective FAIRE site. (c) In all 9 human islet samples that were 
heterozygous for rs7903146, the risk allele T was more abundant than the non-risk C allele 
in the open chromatin fraction, in contrast to input DNA or gDNA from unrelated 
heterozygous individuals. (d) Allelic imbalance for open chromatin at rs7903146 was 
verified in independent assays using quantitative Sanger sequencing (see also 
Supplementary Fig. 4b). (e) The risk allele T of rs7903146 exhibits greater enhancer activity 
than the non-risk allele C in MIN6 cells and (f) 832/13 cells. Standard deviations represent 
four independent clones for each allele. Results for inserts in the reverse direction are 
provided in Supplementary Fig. 4. P-values were calculated by two-sided t-test.
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Table 1
FAIRE-Seq sequence depth and enrichment sites in 3 human islet samples
FAIRE-seq sites
Sequence reads Liberal Moderate Stringent
Sample 1 39,359,429 205,922 99,361 18,189
Sample 2 25,176,624 213,972 91,455 9,601
Sample 3 60,515,180 202,783 81,546 33,305
FAIRE was performed on three human pancreatic islet samples (Methods). Sample 3 had the highest purity (Supplementary Table S1 online), and 
was thus sequenced at greater depth and used for subsequent analysis. Aligned reads were used to call FAIRE sites at three thresholds using F-Seq.
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Table 2
Biological processes enriched among genes associated with islet-selective COREs
PANTHER Biological Process P-Value GO Biological Process P-Value
mRNA transcription regulation 2.25E-24 Small GTPase signal transduction 5.72E-08
Proteolysis 1.45E-22 Vesicle-mediated transport 5.85E-07
mRNA transcription 4.95E-21 Ubiquitin cycle 9.13E-07
Protein modification 4.32E-20 Regulation of signal transduction 3.44E-06
G-protein mediated signaling 7.57E-16 Small GTPase mediated signal transduction 7.57E-06
Cation transport 8.83E-14 Transcription from RNA II promoter 9.15E-06
Protein phosphorylation 1.49E-12 Secretion 1.05E-05
The seven most enriched GO and PANTHER biological process terms are listed. A more comprehensive list is shown in Supplementary Table 6 
online.
Nat Genet. Author manuscript; available in PMC 2010 September 01.
